Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Country Report

Rx/Reimbursement adult incontinence in

Rx/Reimbursement Adult Incontinence in Colombia

Jun 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PRE-COVID-19 PERFORMANCE

Sales growth limited by healthcare company closures

Although taking care of the adult incontinence condition is considered crucial in preserving dignity and quality of life, in 2019 remedying products were still not included in the Colombian Health Benefits Plan (PBS). It is believed to be only a matter of time, however, before they are covered by the Plan and therefore healthcare companies (EPSs) will need to provide these items upon receipt of a health practitioner’s prescription.

Pharmacies offer growth opportunity

In 2019, pharmacies within hospitals and clinics were visibly increasing the shelf space for adult incontinence products, considering that these products were provided by neither hospitals and clinics nor by healthcare insurance companies. Despite its wide distribution network, leading brand manufacturer Productos Familia Sancela SA still regards Farmacia La Rebaja as an important online channel to increase the penetration of adult incontinence products, especially among families with mid-range incomes.

Inclusion on the Health Benefits Plan likely to see companies change strategy

As previously mentioned, in 2019 adult incontinence products were still outside of the Health Benefits Plan, which contains the list of technologies, supplies and medicines that are provided by the healthcare system against a medical prescription. The reimbursement of adult incontinence is covered by FOSYGA (Fondo de Solidaridad y Garantía), a fund created by Law 100 of 1993, which is the basis of the current healthcare system in Colombia and dedicated to cover catastrophic health or personal events and traffic accidents.

2020 AND BEYOND

COVID-19 impact

In 2020, sales of Rx/reimbursement adult incontinence are expected to grow by 2% in 2019 constant value terms, factoring in the impact of COVID-19.

Recovery and opportunities

COVID-19 is likely to have little impact on Rx/reimbursement adult incontinence, with the channel’s supply regulated by healthcare providers, which are less vulnerable to demand surplus than retailers.

Files are delivered directly into your account within a few minutes of purchase.

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

SAMPLES

FAQS ABOUT SAMPLES

DELIVERY

Files are delivered directly into your account within a few minutes of purchase.

OVERVIEW

Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement adult incontinence industry in Colombia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Rx/Reimbursement adult incontinence industry in Colombia, our research will save you time and money while empowering you to make informed, profitable decisions.

The Rx/Reimbursement adult incontinence in Colombia market research report includes:

Analysis of key supply-side and demand trends
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Rx/Reimbursement adult incontinence in Colombia?
What are the major brands in Colombia?
What are the most important channels for Rx/Reimbursement adult incontinence products?
How do light incontinence products perform compared to moderate/heavy incontinence products?

WHY BUY THIS REPORT?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our

Tissue and Hygiene market research database

Want to find out more about this report?

Request more information

Rx/Reimbursement Adult Incontinence in Colombia - Category analysis

HEADLINES

PRE-COVID-19 PERFORMANCE

Sales growth limited by healthcare company closures

Pharmacies offer growth opportunity

Inclusion on the Health Benefits Plan likely to see companies change strategy

2020 AND BEYOND

COVID-19 impact

Recovery and opportunities

CATEGORY DATA

Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2014-2019
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2014-2019
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2019-2024
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2019-2024

Tissue and Hygiene in Colombia - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on tissue and hygiene

COVID-19 country impact

Sanitary protection now more affordable for Colombians

Private label propelled by expansion of hard discounters

Most sales normalisation predicted for 2021 as Colombia recovers from COVID-19

Chart 1 Tissue and Hygiene Value Sales Growth Scenarios: 2017-2024
Chart 2 Tissue and Hygiene Impact of Soft Drivers on Value Sales: 2016-2024

MARKET INDICATORS

Table 5 Birth Rates 2014-2019
Table 6 Infant Population 2014-2019
Table 7 Female Population by Age 2014-2019
Table 8 Total Population by Age 2014-2019
Table 9 Households 2014-2019
Table 10 Forecast Infant Population 2019-2024
Table 11 Forecast Female Population by Age 2019-2024
Table 12 Forecast Total Population by Age 2019-2024
Table 13 Forecast Households 2019-2024

MARKET DATA

Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2014-2019
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2014-2019
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2015-2019
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2016-2019
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2014-2019
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2014-2019
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2019
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2019-2024
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2019-2024

Megatrends

Country Report

Rx/Reimbursement Adult Incontinence in Colombia

New Report Guarantee

Executive Summary

New Report Guarantee

PRE-COVID-19 PERFORMANCE

Sales growth limited by healthcare company closures

Pharmacies offer growth opportunity

Inclusion on the Health Benefits Plan likely to see companies change strategy

2020 AND BEYOND

COVID-19 impact

Recovery and opportunities

Overview

Why buy this report?

SAMPLES

DELIVERY

OVERVIEW

WHY BUY THIS REPORT?

Want to find out more about this report?

Table of Contents

Rx/Reimbursement Adult Incontinence in Colombia - Category analysis

HEADLINES

PRE-COVID-19 PERFORMANCE

Sales growth limited by healthcare company closures

Pharmacies offer growth opportunity

Inclusion on the Health Benefits Plan likely to see companies change strategy

2020 AND BEYOND

COVID-19 impact

Recovery and opportunities

CATEGORY DATA

Tissue and Hygiene in Colombia - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on tissue and hygiene

COVID-19 country impact

Sanitary protection now more affordable for Colombians

Private label propelled by expansion of hard discounters

Most sales normalisation predicted for 2021 as Colombia recovers from COVID-19

MARKET INDICATORS

MARKET DATA

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Recently Viewed

Complete Catalogue

Country Reports